Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE10A | Q9Y233 | 3/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | ACVR1 | Q04771 | 7/20 | 0.38 |
| ▸ | MET | P08581 | 1/20 | 0.36 |
| ▸ | ERN1 | O75460 | 1/20 | 0.35 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.35 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.35 |
| ▸ | GRM4 | Q14833 | 3/20 | 0.33 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.33 |
| ▸ | HTR2B | P41595 | 1/20 | 0.33 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.33 |
| ▸ | BMP4 | P12644 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14499591 | 0.84 | PDE10A (0.44) | PDE10ACYP1A2PIK3CACRBNKCNH2 | |
| SCHEMBL14499583 | 0.83 | PDE10A (0.40) | PDE10ACYP1A2CRBN | |
| SCHEMBL24674409 | 0.81 | PDE10A (0.44) | PDE10ACYP1A2PIK3CACRBNKCNH2 | |
| SCHEMBL14499584 | 0.80 | PDE10A (0.47) | PDE10ACYP1A2PIK3CACRBNKCNH2 | |
| SCHEMBL14499570 | 0.80 | PDE10A (0.42) | PDE10ACYP1A2PIK3CACRBNMAPK10 | |
| SCHEMBL15977658 | 0.76 | PIK3CA (0.50) | CYP1A2ACVR1ERN1PIK3CAAAK1 | |
| SCHEMBL15977435 | 0.76 | ACVR1 (0.50) | CYP1A2ACVR1METERN1PIK3CA | |
| SCHEMBL18999438 | 0.76 | PTGER4 (0.34) | — | |
| SCHEMBL24674275 | 0.76 | CRBN (0.46) | PDE10ACYP1A2PIK3CACRBNKCNH2 | |
| SCHEMBL24674134 | 0.76 | CRBN (0.46) | PDE10ACYP1A2PIK3CACRBNKCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220416178-A1 | COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS | IDEMITSU KOSAN CO.,LTD. (JP) | 2022-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220416178-A1 | COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS | PIEZO1, TMEM109, SLC39A14 | PDE10A 4149/4885CYP1A2 988/4885ACVR1 3843/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.